logo

PLSE

Pulse Biosciences·NASDAQ
--
--(--)
--
--(--)

PLSE fundamentals

Pulse Biosciences (PLSE) expects to report earnings on Feb 19, 2026, with estimated revenue of 150.00K (YoY 0.00%), and EPS at -0.265 (YoY -60.22%).
Revenue estimate / YoY
150.00K
0.00%
EPS estimate / YoY
-0.265
-60.22%
Report date
Feb 19, 2026
Earnings Call
4:30 PM on Feb 19, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

PLSE has released its 2025 Q3 earnings report, with revenue of 86.00K, reflecting a YoY change of NaN%, and net profit of -19.39M, showing a YoY change of -52.88%. The Sankey diagram below clearly presents PLSE's revenue sources and cost distribution.

Key Indicators

Pulse Biosciences (PLSE) key financial stats and ratios, covering profitability, financial health, and leverage.
Pulse Biosciences (PLSE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Pulse Biosciences (PLSE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Pulse Biosciences (PLSE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Pulse Biosciences (PLSE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Pulse Biosciences (PLSE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield